FDX Earnings

FDX reported its FY2026Q2 earnings on 2025-12-18, showcasing a revenue of 23.00B against an estimate of 23.00B, resulting in a 2.94% surprise. The EPS was 4.82, surpassing the expected 4.07 by 18.43% . The stock experienced a 0.58% price change on the earnings day and a 3.06% change over the next five days, reflecting market reactions to the results.

Following FDX's FY2026Q2 earnings announcement on 2025-12-18, the stock price moved by 0.58% on the day of the release. Over the subsequent five days, it saw a 3.06% change. Historically, FDX's stock price tends to shift by an average of -2.08% in the 10 days leading up to earnings and -0.76% in the 10 days following, providing insight into potential market.

For 2026/Q3, analysts estimate FDX’s annual revenue to reach 23.00B, while the EPS is projected at 4.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.1% and EPS estimates Revise Upward by 1.21% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between FDX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were Revise Upward by 0.1%, while EPS estimates moved Revise Upward by 1.21% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, FDX's stock price typically moves by -2.08% in the 10 days before its earnings and -0.76% in the 10 days after. For the upcoming 2026/Q3 earnings, analysts expect an EPS of 4.00 and revenue of 23.00B.

The earnings call presents a balanced outlook with positive elements, such as new Amazon business and expected peak season growth, outweighing concerns like international export pressures. The Q&A reveals management's confidence in overcoming temporary costs and achieving high-end earnings through strong revenue and cost management. Optimistic guidance, transformation savings, and strategic initiatives, such as Network 2.0 and healthcare market focus, support a positive sentiment. However, the lack of specific guidance details and ongoing headwinds temper expectations, leading to a predicted stock price movement of 2% to 8%.